"Designing Growth Strategies is in our DNA"

U.S. In-vitro Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology, and Others), By Setting (Laboratories and Point of Care), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, and Others), By End-user (Clinical Laboratories, Hospitals, Physician’s Offices, and Others), and Forecasts, 2023-2030

Last Updated: May 05, 2025 | Format: PDF | Report ID: FBI107584

 

U.S. In-vitro Diagnostics Market

Request Now
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases in the U.S., 2021/2022
    2. New Product Launches by Key Players
    3. Recent Industry Developments - Mergers & Acquisitions
    4. Overview of Healthcare Expenditure in the U.S.
    5. Technological Advancements
    6. Key Industry Trends
    7. Impact of COVID-19 on the In-Vitro Diagnostics Market
  5. U.S. In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
      2. Clinical Chemistry
      3. Molecular Diagnostics
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Setting
      1. Laboratories
      2. Point of care
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Clinical Laboratories
      2. Hospitals
      3. Physicians Offices
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Abbott
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. F. Hoffmann-La Roche AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Quest Diagnostics Incorporated
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Bio Rad Laboratories, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. BD
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Agilent Technologies, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Quidel Corporation
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Siemens Healthcare GmbH
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  U.S. In-Vitro Diagnostics Market Value Share (%), by Product Type, 2022 & 2030

Figure 2:  U.S. In-Vitro Diagnostics Market Value Share (%), by Technique, 2022 & 2030

Figure 3:  U.S. In-Vitro Diagnostics Market Value Share (%), by Setting, 2022 & 2030

Figure 4:  U.S. In-Vitro Diagnostics Market Value Share (%), by Application, 2022 & 2030

Figure 5:  U.S. In-Vitro Diagnostics Market Value Share (%), by End-user, 2022 & 2030

Figure 6:  U.S. In-Vitro Diagnostics Market Share (%), By Company, 2022 

Table 1:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Product Type, 2019–2030

Table 2:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2019–2030

Table 3:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Setting, 2019–2030

Table 4:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by Application, 2019–2030

Table 5:  U.S. In-Vitro Diagnostics Market Revenue (USD billion) Forecast, by End-user 2019–2030

  • 2019-2030
  • 2022
  • 2019-2021
  • 160
GET A FREE SAMPLE
    The free sample includes data points such as market estimates, growth rate, size of the largest region and segment of the market.
Consulting Services
    How will you benefit from our consulting services ?